Health ❯ Medicine

Pharmaceuticals

Weight Loss Drug Development Weight Loss Drugs Diabetes Clinical Trials Pain Relief Acetaminophen Drug Approval Drug Safety Over-the-Counter Medications

FDA Moves to Add Pregnancy Warning on Acetaminophen as Experts Counter Link to Autism

Medical societies and global regulators say current evidence does not warrant changing guidance for short‑term use in pregnancy.

FDA Clears Second Generic Mifepristone as White House Cites Legal Duty

FDA Opens Tylenol Label Review as Scientists and Global Regulators Reject Autism Claim

Cannabis Extract VER-01 Eases Chronic Low Back Pain in Phase 3 Trial

FDA Opens Mifepristone Safety Review as 20 States Vow to Defend Access

Metsera’s Obesity Drug Posts 14% Placebo-Adjusted Weight Loss, Bolstering Pfizer Buyout Case

After Trump Warns Pregnant Women Off Tylenol, FDA Reviews Labels as Doctors Reject Autism Link

FDA Backs Leucovorin for Cerebral Folate Deficiency as White House Promotes Autism Use

Trump Expands Tylenol Warning to Kids as FDA and Doctors Push Back

WHO, EMA and Pediatric Societies Rebuke Trump’s Claim That Prenatal Tylenol Causes Autism

White House Urges Caution on Tylenol in Pregnancy as FDA Stops Short of Causation

Officials, Doctors Rebuke White House Warning Tying Prenatal Tylenol to Autism

HHS and FDA Open Review of Mifepristone’s Safety and Dispensing

Global Regulators Reject Trump’s Tylenol–Autism Claim as U.S. Issues Pregnancy Advisories

FDA Moves to Authorize Leucovorin for Cerebral Folate Deficiency in Some Autistic Children

Trump Urges Pregnant Women to Avoid Tylenol, Drawing Rapid Pushback From Health Authorities

FDA Approves Leucovorin for Cerebral Folate Deficiency as White House Rolls Out Autism Plan

Bristol Myers’ Iberdomide Combo Hits MRD Goal in Phase 3 Myeloma Study

White House Links Prenatal Tylenol Use to Autism Risk, Plans FDA Warning and Label Review

Roivant’s Brepocitinib Succeeds in 52-Week Dermatomyositis Phase 3 as Companies Target 2026 FDA Filing